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INTRODUCTION
Osseointegration is seen as the close contact 
between bone and implant (1), and the interest on surface 
engineering has to be understood as an important and 
natural trend. The bone response, which means rate, 
quantity and quality, are related to implant surface 
properties. For example, the composition and charges 
are critical for protein adsorption and cell attachment 
(2). Hydrophilic surfaces seem to favor the interactions 
with biological fluids and cells when compared to the 
hydrophobic ones (3,4), and hydrophilicity is affected 
by the surface chemical composition.
Various techniques of surface treatments have 
been studied and applied to improved biological 
surface properties, which favors the mechanism of 
osseointegration (5,6). This strategy aims at promoting 
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the mechanism of osseointegration with faster and 
stronger bone formation, to confer better stability during 
the healing process, thus allowing more rapid loading 
of the implant (7,8).
Some of the objectives for the development of 
implant surface modifications are to improve the clinical 
performance in areas with poor quantity or quality of 
bone, to accelerate the bone healing and thereby allowing 
immediate or early loading protocols and also stimulating 
bone growth in order to permit implant placement in sites 
that lack sufficient residual alveolar ridge, thus providing 
them a jumping gap ability, for example.
Implant morphology influences bone metabolism: 
rougher surfaces stimulates differentiation, growth and 
attachment of bone cells, and increases mineralization; 
furthermore, the degree of roughness is important. 
Implants may have “smooth” (machined) or rough 
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surfaces. The main methods that are reported in 
the literature to create implant roughness are acid 
etching, sandblasting, titanium plasma spraying and 
hydroxyapatite (HA) coating. A current tendency is the 
manufacturing of implants with micro and submicro 
(nano) topography. Furthermore, the biofunctionalization 
of implants surfaces, by adding different substances to 
improve its biological characteristics, has also been 
recently investigated (8-10).
However, the large number of commercially 
available implant types, varying in surface properties 
and other features (11) have to be treated with caution. 
Considering that different methods for implant surface 
engineering may lead to different and unique surface 
properties that might affect the host-to-implant response, 
it seems to be reasonable to test new implant surfaces 
as new biomaterials (12). The evaluation should ideally 
follow a hierarchical approach, where in vitro testing 
followed by in vivo animal studies evolves to clinical 
trials in humans (13).
This paper reviews the literature on dental implant 
surfaces by assessing in vitro and in vivo studies to show 
the current perspective of implant development.
IN VITRO STUDIES
Cell culture models are routinely used to study the 
response of osteoblastic cells in contact with different 
substrates for implantation in bone tissue. Cell cultures 
focused on the morphological aspect, growth capacity 
and the state of differentiation of the cells on materials 
with various chemical, composition and topography (14).
The literature shows that the biochemistry and 
topography of biomaterials’ surfaces play a key role 
on success or failure upon placement in a biological 
environment (15). Wettability, texture, chemical 
composition and surface topography are properties of the 
biomaterials that directly influence their interaction with 
cells (16-18). The interactions of cells and extracellular 
matrix affect directly the cellular processes of adhesion, 
proliferation and differentiation (19). Thus, the surface 
properties of biomaterials are essential to the response 
of cells at biomaterial interface,  affecting the growth 
and quality of newly formed bone tissue (16,17,20).
In the search for new methods, much attention 
has been focused on topographical characteristics, 
especially changes in surface roughness. In vitro studies 
have shown that osteoblastic cells attach, spread and 
proliferate more rapidly on smooth surfaces than on 
rough ones (21). However, osteoblasts present higher rate 
of differentiation and matrix mineralization and higher 
production of growth factors in the presence of rough 
substrates (22). Also, bone matrix proteins, alkaline 
phosphatase and osteocalcin, important indicators of 
osteogenic differentiation and bone tissue formation, 
have been shown to express at higher levels on rougher 
titanium surfaces (23).
The literature has shown that the surface 
topography of titanium can be modified by different 
treatments, in order to obtain a surface with specific 
properties, which have direct influence on the process 
of osseointegration (24,25). It has been suggested that 
surface roughness in 1-2 μm range are beneficial for 
biomechanical anchorage of dental implants (26).
Methods for altering surface texture can be 
classified as either techniques that add particles on the 
biomaterial, creating a surface with bumps (additive 
mechanisms), and techniques that remove material 
from the surface, creating pits or pores (subtraction 
mechanisms). Examples of additive processes are: HA 
and calcium phosphate (CaP) coatings, titanium plasma-
sprayed and ion deposition. Examples of subtraction 
processes are: electro- or mechanical polishing, grit-
blasting, acid-etching, grit-blasting followed by acid-
etching and oxidation (27).
Numerous reports demonstrate that the surface 
roughness of titanium implants affects the rate of 
osseointegration through the speed and amount of 
bone tissue formed at the interface. Comparison of the 
behavior of different cell types on materials shows that 
they are influenced by surface roughness (28).
Roughness gradients of osteoblastic cells increase 
proliferation in close correlation with increasing surface 
roughness. It was observed doubling of the rate of 
osteoblast proliferation on titanium blasted with TiO2 
particles compared to smooth surfaces (29,30). Similar 
results are reported using discs blasted with SiO2 particles 
(31), and Al2O3 particles (29).
Subcultures of rat osteogenic cells grown on 
grit-blasted and acid-etched surfaces demonstrated 
significant formation of bone-like nodules (32). MG63 
osteoblast-like cells (human osteosarcoma cell line) 
cultured on rough titanium surfaces exhibited increased 
adhesion and phenotype differentiation, and higher levels 
of growth factors compared to smooth ones (4).
There is agreement that the microtopography 
creates an environment favorable for cells and cell-
extracellular matrix interactions (33) and increases 
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production of growth factors (34). The microtopography 
provides increased cell differentiation of osteogenic 
cells, resulting in high activity of alkaline phosphatase 
and osteocalcin synthesis (35).
Recent studies have shown that the association of 
different topographies may be beneficial. Indeed, using 
osteogenic cell culture models, synergistic effects of 
substrates with micron- and submicron-scale resulting 
in bone tissue formation have been reported (30,32). 
Titanium surfaces with microtopography and additional 
submicrotopography have been shown to promote early 
development of mineralized matrix, which was observed 
occasionally on the surfaces with microtopography and 
was absent on machined surfaces (36).
The cellular behavior is also influenced by surfaces 
with nanomorphology. The complex interactions cell-
matrix-substrate and cell signaling events occur at the 
nanoscale (37,38). Different signaling pathways regulate 
adhesion, migration, differentiation and gene expression 
in osteoblasts cells (39). Thus, it has been shown that 
different nanotopography influence protein adsorption, 
cell adhesion, cell proliferation and synthesis, and 
secretion of extracellular matrix molecules in vitro (37).
Nanoporous surfaces topography tend to favor 
the proliferation and differentiation processes, acting 
directly on the selective adhesion of osteoblastic cells 
on the surface, which can accelerate the healing process 
around implants (27,37).
In the same way as microstrutureted surfaces, 
nanotopographies can be created by techniques such as 
anodization and oxidation. The production of substrates 
with nanoporous surfaces appears to strongly influence 
the host response at both cellular and tissue levels (12). 
A recent report demonstrated that titanium surfaces 
with nanotopographies obtained from H2SO4/H2O2 
mixture can promote osteoblast proliferation and inhibit 
fibroblast growth (40). It was found that titanium surface 
modifications on the nanoscale alters the adhesion, 
spreading, and growth of osteoblastic cells. Furthermore 
the extracellular accumulation of osteopontin and 
bone sialoprotein, two major bone matrix proteins, 
increased significantly on the titanium substrate with 
nanotopography, indicating that cellular differentiation 
is accelerated, and the proteins are adsorbed more 
efficiently on the nanostrutured substrates (41).
At the present moment, a huge number of 
experimental investigations have clearly demonstrated 
that the bone response is influenced by the implant 
surface topography. Furthermore, more recent data, 
have suggested that titanium surface modifications 
with bioactive molecules enhance and/or accelerates the 
process of osteoblastic differentiation. As the molecules 
are integrated into the structure of the implant, they are 
released gradually, acting as a slow release system of 
osteogenic agents at the implantation site (42) (Fig. 1).
Among all engineering-based implant surface 
modifications, the CaP coating have received significant 
attention (43). The interest of using this material is 
because of its chemical similarity to natural bone, and 
the fact that coatings can be applied along the implant 
surfaces by different industrial processing methods. 
Biomimetic CaP coatings improve the osteoconductivity 
of implants and show promising as slow delivery systems 
for growth factors and other bioactive molecules (44).
Other examples of biochemical modifications of 
biomaterial surfaces are found in the literature, such as 
Figure 1. Epifluorescence of osteogenic cell cultures grown on machined (A), microstructured (B), nanostrutured (C), and synthetic 
peptide coating (D) surfaces at day 3. Red indicates OPN labeling, green reveals actin cytoskeleton, and blue shows cell nuclei. 
Extracellular OPN labeling is abundant and prominent in cultures grown on nanostrutured and synthetic peptide coating surfaces 
(C,D). Scale bar: A-D=50 μm.
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the use of protein-like collagen, bone morphogenetic 
proteins and peptides and/or protein domain (27).
The biological effects that surfaces have on cell 
attachment are mainly mediated by integrins that bind 
to sequences/domains arginine-glycine-aspartate (Arg-
Gly-Asp or RGD) of proteins (45). These Arg-Gly-Asp or 
RGD are expressed in several bone extracellular matrix 
proteins. Titanium surfaces modified with peptides and/
or protein domains with RGD seem to facilitate the 
mechanisms of adhesion and cell signaling via signal 
transduction, which have shown positive effects on the 
differentiation of osteoblasts (46).
Since then, researchers have studied coatings 
based on peptides containing a sequence of amino acids 
to promote cell adhesion to the biomaterial (47). A new 
strategy in the use of bioactive molecules involves the 
addition of extracellular matrix proteins such as collagen. 
Coating titanium surface with collagen enhanced the 
spreading of cells and speeding cell adhesion length 
(48). An in vitro study using bone marrow cells also 
showed that surface coating with collagen type I showed 
high ALP activity, collagen synthesis, and mineralized 
matrix formation (49).
A recent study comparing the development of 
the osteoblastic phenotype of human alveolar bone-
derived cells showed that collagen type I-coated titanium 
surface favors cell growth during the proliferative 
phase and osteoblastic differentiation, as demonstrated 
by changes in mRNA expression profile during the 
matrix mineralization phase. This suggests that surface 
modification may affect bone formation (50).
Some authors have used chemical modification, 
such as addition of fluoride to implant surface, to 
improve the biocompatibility of titanium and promote 
osteogenesis. This process is based on the formation of 
fluorapatite from interaction of fluoride and HA present 
Figure 2. Histologic images evidencing a high level of bone-implant contact achieved with different improvements on implant surfaces. 
A= Sandblasted and acid-etched; B= Nanostructured; C= Anodized; D= Biofunctionalized.
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in bone tissue, followed by promotion of osteoblast 
proliferation and stimulation of alkaline phosphatase 
activity. Currently, there are implants treated with 
fluoride as a biomimetic agent, commercially available 
for clinical use (51).
Despite the interesting results in vitro it seems 
that more research is still needed to enhance our 
understanding of how this surface modifications actually 
promotes fast osseointegration.
IN VIVO ANIMAL STUDIES
In general, cell culture studies evaluate cell 
morphology, adhesion, migration, proliferation and 
differentiation on implant surfaces. However, outcomes 
on the initial biological behavior of new biomaterials 
obtained in vitro cannot be fully correlated to in vivo 
performance. Cell cultures cannot reproduce the dynamic 
environment that involves the in vivo bone/implant 
interaction, and their results can only be confirmed in 
animal models and subsequently in clinical trials (13).
The most frequently used animal models for dental 
bone-implant interface studies are rabbits and dogs. The 
rabbit model has some disadvantages when compared 
to larger animals, such as the size when a number of 
control and experimental implants are recommended per 
animal. Additionally the bone structure of the tibia and 
femur of rabbits (e.g.; the amount of trabecular bone), 
are significantly different when compared to human. 
Otherwise the canine intraoral environment provides 
a bone microstructure with a trabecular/cortical ratio 
similar to that found in the human mandible, in addition 
to similar saliva and microflora.
Irrespective to the different animal models (rat, 
rabbits, sheep, dogs, pigs or nonhuman primates) or 
surgical sites, valuable information can be retrieved from 
properly designed animal studies. Static and dynamic 
histomorphometric parameters plus biomechanical 
testing are recommended as measurable indicators of the 
host/implant response where different surface designs 
are compared. Bone-to-implant contact (BIC), which 
that is the most often evaluated parameter in in vivo 
studies, together with bone density and amount and type 
of cellular content, are examples of static parameters. 
Differently, mineral apposition rate and fluorescence 
analysis temporally evaluates bone modeling/remodeling 
processes. As dynamic measurements, they may provide 
valuable information about the healing around different 
implant surfaces, but these parameters are rarely used. 
Finally, the biomechanical tests (torque, push-out, pull-
out) usually measure the amount of force that a torque 
needs to fail the bone-implant interface surrounding 
different implant surfaces.
Considering the several factors that influence 
the osseointegration, the evaluation of the largest 
possible number of host/implant response parameters 
is desirable for better understanding the bone healing 
around different implant surfaces (Fig. 2), clarifying 
their indications of use and supporting their immediate/
early loading. For descriptive purposes, the physical 
and chemical surface properties will be separated in 
different categories.
Topographic Surface Modifications
Machined implant surfaces represent the starting 
point of implant surface design. They were used for 
decades according to the classical protocols in which 
several months were required for osseointegration (52).
It has been demonstrated that the modification 
on the topographic pattern of surface increases not only 
the bone-implant contact, but also the biomechanical 
interaction of that interface at early implantation periods 
(1). Rough surfaces have found widespread use in oral 
implantology and replaced implants with machined 
surfaces to a great extent in clinical applications (46).
Various methods have been developed in order to 
create a rough surface and improve the osseointegration 
of titanium dental implants. These methods use titanium 
plasma-spraying, blasting with ceramic particles, acid-
etching and anodization.
Titanium plasma-spraying
This method consists in injecting titanium 
powders into a plasma torch at high temperature. The 
titanium particles are projected onto the surface of 
the implants where they condense and fuse together, 
resulting in a titanium plasma sprayed (TPS) coating with 
an average roughness of around 7 μm. This procedure 
increases substantially the surface area of the implants.
Al-Nawas et al. (53) evaluated different types 
of macro and microstructure implant surfaces in a dog 
model. After a healing period of 8 weeks and a loading 
period of 3 months, machined surfaces were compared 
to the TPS counterparts, used as a rough control, and 
also with blasted/acid-etched surface. The evaluation 
of the BIC areas revealed the benefit of rough surfaces 
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relative to machined ones. However, the intra-individual 
difference between the TPS and the blasted/acid-etched 
counterparts showed no significant difference.
In a different animal model, Klokkevold et al. 
(54) compared the torque resistance to remove screw-
shaped titanium implants having a dual acid-etched 
surface (DAE) with implants having either a machined 
surface, or a TPS surface that exhibited a significantly 
more complex surface topography. After implantation, 
the groups of 6 rabbits were sacrificed following 
1-, 2- and 3-month healing periods. Implants were 
removed by reverse torque rotation with a digital torque-
measuring device. Three implants with machined surface 
preparation failed to achieve endosseous integration. All 
other implants were anchored by bone. Mean torque 
values for machined, DAE and TPS implants at 1, 2 
and 3 months were 6.00 ± 0.64 N/cm, 9.07 ± 0.67 N/cm 
and 6.73 ± 0.95 N/cm; 21.86 ± 1.37 N/cm, 27.63 ± 3.41 
N/cm and 27.40 ± 3.89 N/cm; and 27.48 ± 1.61 N/cm, 
44.28 ± 4.53 N/cm and 59.23 ± 3.88 N/cm, respectively. 
Clearly, the stability of DAE implants at the earliest time 
point was comparable to that of TPS implants, while that 
of the machined implants was an order of magnitude 
lower. The TPS implants increased resistance to reverse 
torque removal over the 3-month period. These results 
indicate that dual acid etching of titanium enhances early 
endosseous integration to a level that is comparable to 
that achieved by the topographically more complex TPS 
surfaces. Furthermore, this study confirmed an enhanced 
bone anchorage to rough surface implants as compared 
to machined implants.
TPS processing is one of the methods that further 
increase the surface roughness profile and consequently 
the surface area. Such characteristics recommend its 
use in regions with low bone density (12). However, 
it has to be considered that the increase in surface area 
that represents an effective increase in osseointegration 
area provides spaces greater than 50 μm that facilitates 
the migration of pathogens when the implant surface is 
exposed to the oral fluids.
Blasting with ceramic particles/acid-etching
Surface acid-etching and grit-blasting/acid-
etching are very diffuse methods to obtain rough implant 
surfaces. A great part of the commercially available grit-
blasted implant surfaces are subsequently acid-etched.
Generally, the grit-blasting procedure is 
performed by propulsion of particles of different sizes 
of silica (sand), alumina, titanium oxide or CaP for 
example. The most commonly used acid-etching agents 
are hydrofluoric, nitric, sulfuric acids and combinations. 
An example of this group of surfaces was investigated by 
Sammons et al. (55), evidencing a Ra value of 2.75 μm 
and irregular micropores with approximately 3-5 μm in 
diameter and 2-3 μm in depth. Even smaller micropores 
are located within these micropores. 
Novaes et al. (56) compared grit-blasted/acid-
etched implants to titanium plasma spray implants 
immediately installed into periodontally infected sites. 
The histomorphometric analyses showed percentages 
of bone to implant contact of 52.7% and 42.7% for 
grit-blasted/acid-etched implants and titanium plasma 
spray implants, respectively. The bone density analysis 
revealed percentages of 66.6% and 58.8% in the adjacent 
areas of grit-blasted/acid-etched implants and titanium 
plasma spray implants, respectively. These differences 
between the groups were not statistically significant, 
but indicated a slightly better performance of the grit-
blasted/acid-etched surfaces when compared to the 
titanium plasma spray surface, even in a challenging 
healing situation.
Recently, it was seen that changing the 
sterilization and storage method of an original sand-
blasted/acid-etched surface is another possible way to 
modify implant surface. In other words, the new surface 
is rinsed under nitrogen protection to prevent exposure 
to air and then stored in a sealed tube containing an 
isotonic saline solution (4). This treatment obtains the 
hydroxylation of titanium oxides without changing the 
surface topography, this procedure improved the surface 
wettability of the new surface when compared to the 
original one in a statistically significant level (57).
According to animal experiments, both 
biomechanical and histomorphometric evaluations 
showed better results for the modified surface compared 
to the original sand-blasted/acid-etched surface at early 
periods. In the miniature pig model, Buser et al. (58) 
investigated the interfacial stiffness values, which were 
calculated from the torque-rotation curve, and found on 
average 9-14% higher values for the modified surface 
compared to the original sand-blasted/ acid-etched 
surface. This difference was statistically significant 
and they concluded that the modified provided better 
bone anchorage than the original surface. Moreover, 
Schwarz et al. (59) evaluated the bone regeneration in 
dehiscence-type defects with these implants in beagle 
dogs. After 2 weeks of healing, the modified group 
Braz Dent J 21(6) 2010
Implant surfaces in osseointegration 477
achieved 74% of BIC, while the original group achieved 
56%, and this difference was statistically significant. 
However, after 12 weeks of healing, BIC was 84% for 
the modified group and 76% for the original group, 
without statistically significant and this difference. Thus, 
it could be concluded that the modified implant surface 
promoted enhanced bone apposition during the early 
stages of bone formation. In accordance to this, Bornstein 
et al. (60) comparing the same implant surfaces in a dog 
model, showed significantly higher percentage of bone 
in contact with the modified surface when compared 
to the original sand-blasted/acid-etched surface after 2 
weeks, but no statistically significant difference after 
4 weeks of implantation. These results suggest that a 
chemical modification on a microstructured implant 
surface may interfere in the biomechanical and bone 
apposition properties at early phases after implantation.
Electrochemical anodization
Another method that has been shown to increase 
surface microtexture and change surface chemistry 
is electrochemical anodization. The combination of 
potentiostatic or galvanostatic anodization of titanium in 
strong acids at high current density or potential, results in 
thickening of the titanium oxide layer. Anodized surfaces 
interfere positively in bone response with higher values 
for biomechanical and histomorphometric tests when 
compared to machined surfaces (61,62).
Burgos et al. (63) selected a commercially implant 
surface manufactured by anodic oxidation to compare 
to turned surfaces in a rabbit model. BIC values were 
20% (after 7 days), 23% (after 14 days), and 46% (after 
28 days) around the oxidized surfaces and 15% (after 
7 days), 11% (after 14 days), and 26% (after 28 days) 
around the machined surfaces. It was concluded that the 
moderately rough oxidized surfaces follows a different 
pattern of osseointegration.
Differently, Huang et al. (64) evaluated the 
oxidized implant surfaces installed in the posterior 
maxilla of monkeys. After 16 weeks, the mean BIC 
was of 74%. The authors suggested that this oxidized 
surface detains a considerable osteoconductive potential 
promoting a high level of implant osseointegration in 
type IV bone in the posterior maxilla.
CaP coatings
Up to now, plasma-spraying remains as the  most 
widely used commercial CaP implant surface coating. 
CaP ceramics are considered to have bioactive properties, 
which involves the strong interaction between materials 
and surrounding bone by means of a chemical bonding 
(2). Substrates containing CaP coating is expected to 
render a faster biological fixation between implant 
and bone tissue when compared to those without CaP 
coatings (65-67). However, the thick and non-uniform 
coating performed by the plasma-spraying method, 
in which HA ceramic particles are injected into a 
plasma torch at high temperature and projected on 
to the surface of the titanium, have also been related 
to some disadvantages. The possible delamination 
of the coating from the implant surface is generally 
highlighted, making possible the clinical failure of the 
implant (68). Additionally, the transmucosal zone of 
plasma sprayed HA implants represents a challenge 
(43) in terms of periimplantitis infection. Based on 
these reasons, the clinical use of the plasma sprayed HA 
implants decreased, but the osteoconductive property of 
this bioactive ceramic coating remains as a factor that 
may contribute to additional bone attachment in areas 
of poor quality or quantity of bone.
As a new trend, the changes of surface roughness 
at the nanoscale level seem to strongly influence the 
host response at both cellular and tissue levels. In this 
context, it should be mentioned that some strategies 
have been developed to improve the plasma sprayed 
HA coating process. Thus methods such as sol-gel 
deposition, electrophoretic deposition and discrete 
crystalline deposition were developed in order to obtain 
significant thinner coating thicknesses when compared 
to the plasma sprayed HA technique.
It is already available for clinical use the result 
of a CaP nanoparticle modification of a minimally 
rough titanium implant surface. It has been created by 
the combination of the sol-gel and discrete crystalline 
deposition (DCD) of CaP. Mendes et al. (69) suggested 
that the nano-feature size of the tightly adherent adsorbed 
CaP/DCD crystal is of 20-100 nm.
In the rat model, Mendes et al. (70) have shown 
significantly greater average disruption forces with 
DCD samples when compared to dual acid-etched 
samples. The authors concluded that an increase in 
the complexity of the surface topography can render a 
bone-bonding ability. Recently, the same group, again 
in the rat model (71), demonstrated significant increase 
in osteoconduction as a function of the enhanced surface 
nanotopography obtained by the CAP nanocrystals in 
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the rat model.
In summary, highly roughened implants, such as 
TPS or grit-blasted implants, have been shown to favor 
mechanical anchorage and primary fixation to bone, 
while topographies in the nanometer level focus on the 
enhancement of the host response by means of promoting 
protein adsorption and osteoblastic cell adhesion during 
the early stages of healing in the periimplant region.
BIOMIMETIC SURfACE MODIfICATIONS
Biomolecules coated onto titanium surface
A common theme in the engineering of cell and 
tissue behavior on device surfaces is to modify the 
material to selectively interact with a specific cell type 
through biomolecular recognition events. Typically, 
peptides containing the cell-binding domains found 
in the extracellular matrix proteins are immobilized 
on the material to promote cell adhesion via ligand-
receptor interaction (72,73). Integrins are an example 
of cell adhesion receptors that bind to specific amino 
acid sequences, such as the RGD that is found in type I 
collagen, fibronectin, osteopontin and bone sialoprotein. 
Apart from cell attachment, extracellular matrix may 
also act on cellular migration and proliferation events.
The concept of functionalizing the implant 
surfaces with native or synthetic molecules based on 
peptides, proteins and growth factors emerged from the 
hypothesis that the ability of imitating the environment 
of bone, which is composed of an organic matrix (mainly 
collagenous proteins) and inorganic CaP, could enhance 
the implant surface performance, encouraging the initial 
biologic response.
Animal studies support the in vivo osteoconductive 
potential of the RGD peptide sequence as a potential 
method of functionalizing titanium implant surfaces. In 
the dog model, Schliephake et al. (46) compared implants 
with machined titanium surface, coated with collagen 
I, coated with collagen I and low RGD concentrations 
(100 μmol/mL), and coated with collagen I and high 
RGD concentrations (1000 μmol/mL). The BIC and 
volume density of the newly formed periimplant bone 
(BVD) was assessed histomorphometrically after 1 
and 3 months. After 1 month, BIC was significantly 
enhanced only in the group of implants coated with the 
higher concentration of RGD peptides. Volume density 
of the newly formed periimplant bone was significantly 
higher in all implants with organic coating. No significant 
difference was found between collagen coating and RGD 
coatings. After 3 months, BIC was significantly higher in 
all implants with organic coating than in implants with 
machined surfaces. Periimplant BVD was significantly 
increased in all coated implants in comparison to 
machined surfaces. The authors concluded that organic 
coating of machined screw implant surfaces providing 
binding sites for integrin receptors can enhance bone 
implant contact and periimplant bone formation. In 
addition, Germanier et al. (74) compared RGD peptide 
polymer modified implant surfaces with sandblasted and 
acid-etched implant surfaces placed in the maxillae of 
miniature pigs, and confirmed that the functionalization 
may promote enhanced bone apposition during the early 
stages of bone regeneration. 
However,it should be mentioned that the success 
of such functionalization seems to be strongly dependent 
on type, delivery and concentration of the coating. For 
example, some studies showed confusing results when 
evaluating implant surfaces modified by BMP coatings. 
BMPs are a class of growth factors that promote 
bone formation, but they also stimulate the action of 
osteoclasts. It seems that the dose of the drug is critical 
for the final result.
Liu et al. (75) evaluated the effects of BMP-2 
and its mode of delivery on the osteoconductivity of 
dental implants with either a naked titanium surface 
or a calcium-phosphate-coated one in the maxillae 
of miniature pigs. After 3 weeks, the volume of bone 
deposited within the osteoconductive space (periimplant) 
was highest for coated and uncoated implants bearing 
no BMP-2, while the lowest value was achieved with 
coated implants bearing only adsorbed BMP-2. It was 
concluded that the osteoconductivity of functionalized 
implant surfaces depends on the mode of BMP-2 
delivery, being drastically impaired when BMP-2 was 
present as a superficially adsorbed depot upon CaP 
coated or uncoated surfaces.
In a different dog model, Wikesjö et al. (76) 
studied the ability of recombinant human BMP-2 
(rhBMP-2) coated onto a titanium porous oxide 
implant surface to stimulate local bone formation, 
including osseointegration and vertical augmentation 
of the alveolar ridge. Thus critical-size, 5 mm, supra-
alveolar, periimplant defects were created and implants 
coated with rhBMP-2 at 0.75 or 1.5 or 3.0 mg/mL or 
uncoated control were installed and compared. The 
histologic evaluation showed newly formed bone with 
characteristics of the adjoining resident type II bone 
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including cortex formation for sites receiving implants 
coated with rhBMP-2 at 0.75 or 1.5 mg/mL. Sites 
receiving implants coated with rhBMP-2 at 3.0 mg/mL 
exhibited more immature trabecular bone formation, 
seroma formation and periimplant bone remodelling 
resulting in undesirable implant displacement. Control 
implants exhibited minimal, if any, bone formation. In 
summary, rhBMP-2 coating onto titanium porous oxide 
implant surfaces induced clinically relevant local bone 
formation including vertical augmentation of the alveolar 
ridge and osseointegration, but higher concentrations/
doses were associated with negative effects.
Finally, non-BMP growth factors have also been 
tested as potential agents to improve the osseointegration 
parameters. Park et al. (77) evaluated the osseointegration 
of anodized titanium implants coated with fibroblast 
growth factor-fibronectin (FGF-FN) fusion protein that 
were placed in rabbit tibiae. The removal torque values 
as well as the percentages of BIC of the test group were 
better than those found for the implants that were not 
biofunctionalized.
CONCLUDING REMARKS
There are a huge number of types of implant 
surfaces in the market, from different implant 
manufacturers, all of them claiming to have better clinical 
results. It is important that the clinician selects for use in 
their patients the surfaces that have shown good results 
in the scientific literature.
The majority of  currently available in vitro and in 
vivo studies seem to indicate that implant surfaces with 
micro and submicro (nano) topography bring forward 
benefits to the process of interaction between bone cells 
and implant surfaces, accelerating and increasing the 
quality of BIC.
Finally, based on the state of the art of implant 
development, it is possible to predict that, within some 
time, implant surfaces coated with substances with 
biomimetic capacity will be available for clinical use. 
This process of biofuncionalization of implant aims at 
modulating new bone formation around implants, and 
it is the next step in implant development.
RESUMO
A fixação biológica entre as superfícies de implante e os ossos 
maxilares deve ser considerada como um pré-requisito para o 
sucesso em longo prazo de próteses implanto-suportadas. Neste 
contexto, as modificações nas superfícies de implante ganharam 
um lugar importante e decisivo na pesquisa em Implantodontia 
nos últimos anos. Sendo o tópico mais estudado, colaboraram 
para o melhoramento de modalidades de tratamento dental, assim 
como para a expansão de uso dos implantes dentais. Hoje, um 
grande número de diferentes implantes com uma grande variedade 
de propriedades de superfícies, entre outras características, está 
comercialmente disponível e isto deve ser tratado com cuidado. 
Apesar das modificações nas superfícies terem melhorado 
a osseointegração em tempos precoces de implantação, por 
exemplo, o clínico deve procurar evidências científicas antes de 
selecionar um implante dental para uso específico. Este artigo 
fará uma revisão da literatura sobre superfícies de implantes 
osseointegráveis, analisando estudos in vitro e in vivo, a fim de 
mostrar uma perspectiva atual do desenvolvimento dos implantes. 
Esta abordagem englobará os resultados obtidos com micro e nano 
topografias, em termos quantitativos e qualitativos, avaliando 
a interface osso-implante. Além disso, discutirá também as 
perspectivas da incorporação de substâncias biomiméticas (como 
peptídeos e proteínas morfogenéticas) à superfície dos implantes 
e seus efeitos na modulação da neoformação óssea periimplantar.
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